Antidepressant medication and pregnancy: time for randomized controlled trials

Area of Science:

• Perinatal mental health
• Clinical pharmacology
• Developmental pediatrics

Background:

• Depression is prevalent in pregnant women, with common antidepressant use.
• Current evidence relies on observational studies with inherent biases.
• Existing systematic reviews and guidelines offer inconsistent recommendations.

Purpose of the Study:

• To address the lack of prospective randomized controlled trials (RCTs) on antidepressant use during pregnancy.
• To evaluate the efficacy and safety of antidepressants in depressed pregnant women.
• To determine the effects of prenatal antidepressant exposure on neonates and child development.

Main Methods:

• The abstract highlights the need for well-designed, prospective RCTs.
• These trials should compare antidepressant drug exposure versus placebo exposure.
• Long-term follow-up of neonates and children is crucial.

Main Results:

• No specific results are presented as the abstract calls for new research.
• Current data is insufficient to definitively answer key questions.

Conclusions:

• There is a critical need for rigorous RCTs to establish antidepressant efficacy and safety in pregnancy.
• Understanding the risks of untreated maternal depression versus medication exposure is essential.
• Clearer guidance for clinicians and patients requires robust prospective data.